David M Cutler
Overview
Explore the profile of David M Cutler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
149
Citations
4515
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Nakamoto C, Cutler D, Beaulieu N, Uscher-Pines L, Mehrotra A
Health Aff (Millwood)
. 2024 Apr;
43(5):691-700.
PMID: 38630943
Telemedicine use remains substantially higher than it was before the COVID-19 pandemic, although it has fallen from pandemic highs. To inform the ongoing debate about whether to continue payment for...
12.
Kakani P, Cutler D, Rosenthal M, Keating N
JAMA Netw Open
. 2024 Feb;
7(2):e2356592.
PMID: 38373001
Importance: Increasing integration across medical services may have important implications for health care quality and spending. One major but poorly understood dimension of integration is between physician organizations and pharmacies...
13.
14.
15.
16.
Nguyen C, Beaulieu N, Wright A, Cutler D, Keating N, Landrum M
J Clin Oncol
. 2023 Jun;
41(26):4226-4235.
PMID: 37379501
Purpose: To describe the supply of cancer specialists, the organization of cancer care within versus outside of health systems, and the distance to multispecialty cancer centers. Methods: Using the 2018...
17.
18.
Beaulieu N, Chernew M, McWilliams J, Landrum M, Dalton M, Gu A, et al.
JAMA
. 2023 Jan;
329(4):325-335.
PMID: 36692555
Importance: Health systems play a central role in the delivery of health care, but relatively little is known about these organizations and their performance. Objective: To (1) identify and describe...
19.
Enzinger A, Ghosh K, Keating N, Cutler D, Clark C, Florez N, et al.
J Clin Oncol
. 2023 Jan;
41(14):2511-2522.
PMID: 36626695
Purpose: To characterize racial and ethnic disparities and trends in opioid access and urine drug screening (UDS) among patients dying of cancer, and to explore potential mechanisms. Methods: Among 318,549...
20.